New York Times Editorial on Heparin: American Public Vulnerable to Toxic Imports

Hundreds of patients have now fallen ill due to the toxic batches of Heparin emanating from China.

In response, a New York Times editorial on April 28, 2008, cites the "sloppy manufacturing processes" involved and warns that it is essential that "American companies, eager to cut cost by outsourcing, are especially diligent about monitoring their suppliers.

Some lots of heparin, whose main ingredient was made from pig intestines and imported from China, were contaminated with a cheaper substance derived from animal cartilage, Baxter and the FDA said last month.

This warning comes too late for those patients that have experienced severe side effects or even death after receiving Heparin bloodthinnner.

The Food and Drug Administration has now linked the contaminated drug to 81 deaths in the United States.

"All companies must ensure the quality and safety of what they buy and what they sell," said the Times.

If you were harmed after being administered heparin, please complete the form below and a representative of our firm will contact you as soon as possible.

Click To Talk To Us Online

Heparin Batches

Heparin Batches Pulled in Europe Amid Safety Worries--Free Legal Info
Tainted Batches of Heparin Spawn Lawsuits--Attorneys Reviewing Cases

Heparin Recalls

Baxter Recalls Heparin--FDA Search for Source of Lethal Contamination
Baxter recalls heparin as investigation continues--Free Lawsuit Info

Heparin News

Breaking News: Baxter Recalls Most Heparin Products After 4 Die
Heparin Pulled From Market After News of Illness--Free Lawsuit Info

Name

Phone

strictly confidential

Your Question

Email Address
When were you given Heparin?
Why were you given Heparin?
How were you injured by Heparin?
What was the date of your Heparin injury?
Name
Phone Number (optional)